Early Treatment of ARNI on Myocardial Remodeling and Progress

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 280 participants.

Also called NCT04342351

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04342351
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04342351. Randomized; double masking; primary purpose treatment. Start 2020-05-01 (anticipated); primary completion 2021-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Treatment of ARNI on Myocardial Remodeling and Progress
Intervention (Drug)
sacubitril/valsartan
Intervention (Drug)
perindopril
Intervention (Other)
Cardiopulmonary Exercise Test
Intervention (Other)
Echocardiogram
Lead sponsor
RenJi Hospital (class: other)

Record details

Record id
cardio:ct-nct04342351
Content hash
aac973a9282af4eecb23a4c5992fac9d494abcd889b8d0d7cb3993a370a5aa01